$SRTS News

Last published 19h ago

19h agoSRTSSensus Healthcare, Inc. - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
19h agoSRTSSensus Healthcare Reports Third Quarter 2026 Financial Results and Business HighlightsBusiness WireBOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended September 30, 2026. Highlights included: Revenues of $6.0 million compared with $6.9 million in t ...
3d agoSRTSSensus Healthcare Announces Sale of 1,000th SRT System, Marking Significant Commercial MilestoneBusiness WireBOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the sale of its 1,000th superficial radiotherapy (SRT) system, representing an important achievement in the Company's commercial development. This sale underscores Se ...
2w agoSRTSSensus Healthcare to Report Third Quarter 2026 Financial Results and Hold Business Update Conference Call on November 12, 2026Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will
2mo agoSRTSJoe Sardano, co-founder, chairman and CEO of Sensus Healthcare | The Big Biz Show - SENSUS HEALTHCARE INCEarnings Call TranscriptsJoe Sardana, our favorite Hall of Fame basketball player, as well as the CEO of Census Healthcare, their ticker symbol, SRTS, this is really interesting because you've got medical dermatology and you've Got aesthetic der
3mo agoSRTSSensus Healthcare Reports Second Quarter 2026 Financial Results and Business HighlightsBusiness WireCommercial Momentum Builds Following CPT Code Implementation Revenue Recognition on Eight Purchased Units Shifted to Q3 Due to Financing Approval Timing CMS Proposed 26% Increase in Hospital-Based Delivery Code,
3mo agoSRTSSensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will
6mo agoSRTSSensus Healthcare Reports First Quarter 2026 Financial Results and Business HighlightsBusiness WireDedicated CPT Codes for Superficial Radiotherapy (SRT) Now Effective, Driving Increased Customer Activity, Customer Diversification and Improved Physician Economics Sales Pipeline and Financing Activity Strengthen
6mo agoSRTSSensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will
7mo agoSRTSSensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of ContractBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today
8mo agoSRTSSensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed BaseBusiness WireProprietary cloud-based software and add-on solution designed to provide current and future SRT-100 users with enhanced workflow, operating intelligence and clinical utility Creates a scalable, recurring-revenue
8mo agoSRTSSensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT TechnologyBusiness WireNew financing program provides a "one-stop" pathway for practices to acquire systems through outright purchase or several attractive leasing alternatives Supports improved conversion of late-stage prospects as
9mo agoSRTSSensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin CancerBusiness Wire2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to delivery code that became effective January 1, 2026 Company enters 2026 with reimbursement certainty and strategic visibility,
9mo agoSRTSSensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
12mo agoSRTSSensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial OfficerBusiness WireNew responsibilities recognize Mr. Sardano's significant accomplishments in securing CPT® codes for office-based SRT and the growing commercial opportunity the Company now faces Sensus Healthcare, Inc.
1y agoSRTSSensus Healthcare Named to TIME's America's Growth Leaders of 2026Business WireRecognition in top 100 of this inaugural ranking of 500 companies reflects five-year growth performance, financial stability and stock performance Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company
1y agoSRTSSensus Healthcare Announces the Passing of Director Bill McCallBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSStudy Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare's SRT Combined with Punch Excision to Treat KeloidsBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoSRTSSensus Healthcare Reports Second Quarter 2025 Financial ResultsBusiness WireShipped 19 SRT systems during the quarter, including four to China Revenues of $7.3 million FDA treatment volume increased 27% over the first quarter Exited the quarter with $22.2 million in cash and no
1y agoSRTSSensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSReceipt of MDSAP Certification for Sensus Healthcare's Full SRT Product Portfolio to Streamline and Accelerate International Sales EffortsBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation OncologistsBusiness WireStrategic Partnership Targets U.S. Market Expansion of Superficial Radiotherapy Systems into Hospital-Based and Freestanding Oncology Centers Sensus Healthcare, Inc. (NASDAQ:SRTS) (Sensus or the Company), a medical
1y agoSRTSSensus Healthcare Reports First Quarter 2025 Financial ResultsBusiness Wire21 SRT systems shipped during the quarter; revenues of $8.3 million 65% increase in treatment volume from FDAs over preceding quarter Profitability forecast for the next three quarters and for the full
1y agoSRTSSensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive TreatmentsBusiness WireInnovative SRT-100 Vision (IG-SRT) and SRT Vision Technologies allow dermatologists to treat non-melanoma skin cancer without surgery or patient downtime May is Skin Cancer Awareness Month and Sensus Healthcare, Inc.
1y agoSRTSSensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare to Participate in the 37th Annual ROTH ConferenceBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual MeetingBusiness WireFull line of SRT products along with innovative pre-commercial products including portable lesion detection and TransDermal Infusion to be featured in a brand-new, A.I.-focused environment at Booth #2451 Sensus
1y agoSRTSSensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid RecurrenceBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare Buys Back SharesBusiness WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSSensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness WireShipped a record 39 SRT systems during the quarter; revenues of $13.1 million Achieved fifth consecutive quarter of profitability; diluted EPS of $0.09 Conference call begins at 4:30 p.m. Eastern time today Sensus
1y agoSRTSSensus Healthcare to Present at The Microcap Conference 2025Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today
1y agoSRTSSensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025Business WireSensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions,
1y agoSRTSPompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile ConfigurationGlobeNewswireFull-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits BOCA RATON, Fla, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc.
1y agoSRTSREVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third QuarterGlobeNewswireThis revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer's request. The agreement
1y agoSRTSSensus Healthcare, Inc. (SRTS) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoSRTSSensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third QuarterGlobeNewswireRevenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year agoSigned a Fair Deal Agreement with Platinum
2y agoSRTSSensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024GlobeNewswireBOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
2y agoSRTSSensus Healthcare Sells SRT System to Providence Swedish HospitalGlobeNewswireBOCA RATON, Fla., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for
2y agoSRTSSensus Healthcare, Inc. (SRTS) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoSRTSSensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second QuarterGlobeNewswireRevenues of $9.2 million compares with $4.5 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $2.1 million compares with negative $1.0 million a year ago"Fair Deal Agreement" recurring revenue
2y agoSRTSSensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024GlobeNewswireBOCA RATON, Fla. , Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
2y agoSRTSSensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024GlobeNewswireBOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
2y agoSRTSSensus Healthcare, Inc. (SRTS) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoSRTSSensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-foldGlobeNewswireRevenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarterLaunched the "Fair Deal
2y agoSRTSLargest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare's SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and CatsGlobeNewswireFirst veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective,
2y agoSRTSSkinCure Oncology's GentleCure™ Experience to be Featured in National Public Health PSA SeriesGlobeNewswireBURR RIDGE, Ill., May 08, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT, presented as
2y agoSRTSSensus Healthcare Announces Sale of First SRT-100 Vision™ System to AsiaGlobeNewswireReminder: First Quarter 2024 Financial Results Reporting and Conference Call on May 9, 2024 BOCA RATON, Fla, May 06, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company
2y agoSRTSSensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024GlobeNewswireBOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological